Picture of All Cosmos Bio-Tech Holding logo

4148 All Cosmos Bio-Tech Holding Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
Basic MaterialsBalancedSmall CapSuper Stock

Annual cashflow statement for All Cosmos Bio-Tech Holding, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line322634258253297
Depreciation
Amortisation
Non-Cash Items-43.533.8-39.7-14.313.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-394-673692-238-124
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-67.643.895954.2253
Capital Expenditures-104-60.9-163-142-43.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-4.3256.2-39.6-86.2-234
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-108-4.67-203-228-278
Financing Cash Flow Items-2.18-12.212.4-42.5-0.011
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities196490-550-42882.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-21.4601117-52589.2